Natus Medical
Leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical.
Launch date
Employees
Market cap
-
Enterprise valuation
€1.0b (Public information from Jul 2022)
Share price
$32.96
San Carlos California (HQ)
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | - | - | 483m | 451m | 378m | 429m | 437m |
% growth | - | - | - | (7 %) | (16 %) | 13 % | 2 % |
Profit | - | - | (20.0m) | (12.7m) | (14.5m) | 20.0m | 30.0m |
% profit margin | - | - | (4 %) | (3 %) | (4 %) | 5 % | 7 % |
EV / revenue | - | - | 2.1x | 2.3x | 1.6x | 1.7x | 1.7x |
R&D budget | 32.0m | 43.0m | 54.0m | 52.0m | - | - | - |
R&D % of revenue | - | - | 11 % | 12 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $55.0m | IPO | |
$30.8m | Post IPO Equity | ||
* | $1.2b Valuation: $1.2b 2.5x EV/LTM Revenues | Acquisition | |
Total Funding | - |
Related Content
Recent News about Natus Medical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Natus Medical
EditACQUISITION by Natus Medical Sep 2009
ACQUISITION by Natus Medical Jul 2009
ACQUISITION by Natus Medical Jan 2013
ACQUISITION by Natus Medical Nov 2020
ACQUISITION by Natus Medical Dec 2022